Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma

Affiliations

¹ Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
³ Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands.
⁴ Department of Radiotherapy, Radboud University Medical Centre, Nijmegen, the Netherlands.
⁵ Department of Radiotherapy, Erasmus Medical Centre, Rotterdam, the Netherlands.
⁶ Department of Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands.
⁷ Department of Haematology, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands.
⁸ Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands.
⁹ Department of Radiotherapy, MAASTRO Clinic, Maastricht, the Netherlands.
¹⁰ Department of Haematology, Reinier de Graaf Group, Delft, the Netherlands.
¹¹ Department of Haematology, Isala, Zwolle, the Netherlands.
¹² Department of Radiotherapy, Zeeuws Radiotherapy Institute, Vlissingen, the Netherlands.
¹³ Department of Haematology, Adrz Hospital, Goes, the Netherlands.
¹⁴ Department of Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
¹⁵ Department of Haematology, Amphia Hospital, Breda, the Netherlands.
¹⁶ Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.

Annelies Nijdam et al. Br J Haematol. 2019 Aug.

. 2019 Aug;186(4):e103-e108.

doi: 10.1111/bjh.15936. Epub 2019 May 15.

¹ Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
³ Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands.
⁴ Department of Radiotherapy, Radboud University Medical Centre, Nijmegen, the Netherlands.
⁵ Department of Radiotherapy, Erasmus Medical Centre, Rotterdam, the Netherlands.
⁶ Department of Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands.
⁷ Department of Haematology, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands.
⁸ Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands.
⁹ Department of Radiotherapy, MAASTRO Clinic, Maastricht, the Netherlands.
¹⁰ Department of Haematology, Reinier de Graaf Group, Delft, the Netherlands.
¹¹ Department of Haematology, Isala, Zwolle, the Netherlands.
¹² Department of Radiotherapy, Zeeuws Radiotherapy Institute, Vlissingen, the Netherlands.
¹³ Department of Haematology, Adrz Hospital, Goes, the Netherlands.
¹⁴ Department of Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
¹⁵ Department of Haematology, Amphia Hospital, Breda, the Netherlands.
¹⁶ Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.

No abstract available

Keywords: Hodgkin lymphoma; long-term adverse effects; screening guidelines; survivorship care.

Publication types